Signature gene expression profile of triclosan-resistant Escherichia coli

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 6, 2010, Pages 1171-1177

  Yu, Byung Jo ^a   Kim, Jung Ae ^a   Pan, Jae Gu ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

DNA microarray; E. coli; FabI; Triclosan MIC

Indexed keywords

AMPICILLIN; ARABINOSE; BACTERIAL DNA; BACTERIAL RNA; CARBAMOYLTRANSFERASE; CARRIER PROTEIN; CHLORAMPHENICOL; FORMATE DEHYDROGENASE; GLYCEROL DEHYDROGENASE; GLYCINE; HEAT SHOCK PROTEIN; MEMBRANE PROTEIN; METHIONINE SULFOXIDE REDUCTASE B; NITRATE REDUCTASE; NITRATE TRANSPORTER; NITROSOGUANIDINE; OXIDOREDUCTASE; PILIN; PORIN; REGULATOR PROTEIN; TRICLOSAN; VALINE;

ALLELE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL GENETICS; BACTERIAL STRAIN; CODON; DNA MICROARRAY; ESCHERICHIA COLI; GENE CASSETTE; GENE EXPRESSION PROFILING; GENE MUTATION; GENE OVEREXPRESSION; GENETIC RECOMBINATION; MICROARRAY ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MUTAGENESIS; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; STRAIN DIFFERENCE; TRANSPORT KINETICS;

AMINO ACID SUBSTITUTION; ANTI-INFECTIVE AGENTS, LOCAL; DRUG RESISTANCE, BACTERIAL; ENOYL-(ACYL-CARRIER-PROTEIN) REDUCTASE (NADH); ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION PROFILING; GENES, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS, SITE-DIRECTED; MUTAGENS; MUTANT PROTEINS; NITROSOGUANIDINES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECOMBINATION, GENETIC; TRICLOSAN;

EID: 77953531054     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq114     Document Type: Article

References (22)

1. Bhargava HN, Leonard PA. Triclosan: applications and safety. Am J Infect Control 1996; 24: 209-18.
2. Jones RD, Jampani HB, Newman JL et al. Triclosan: a review of effectiveness and safety in health care settings. Am J Infect Control 2000; 28: 184-96.
3. McMurry LM, Oethinger M, Levy SB. Triclosan targets lipid synthesis. Nature 1998; 394: 531-2.
4. Heath RJ, Rock CO. Microbiology: a triclosan-resistant bacterial enzyme. Nature 2000; 406: 145-6.
5. McMurry LM, McDermott PF, Levy SB. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrob Agents Chemother 1999; 43: 711-3.
6. McLeod R, Muench SP, Rafferty JB et al. Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of apicomplexan FabI. Int J Parasitol 2001; 31: 109-13.
7. Levy CW, Roujeinikova A, Sedelnikova S et al. Molecular basis of triclosan activity. Nature 1999; 398: 383-4.
8. Heath RJ, White SW, Rock CO. Lipid biosynthesis as a target for antibacterial agents. Prog Lipid Res 2001; 40: 467-97.
9. Heath RJ, Rubin JR, Holland DR et al. Mechanism of triclosan inhibition of bacterial fatty acid synthesis. J Biol Chem 1999; 274: 11110-4.
10. Russell AD. Mechanisms of antimicrobial action of antiseptics and disinfectants: an increasingly important area of investigation. J Antimicrob Chemother 2002; 49: 597-9.
11. Russell AD. Similarities and differences in the responses of microorganisms to biocides. J Antimicrob Chemother 2003; 52: 750-63.
12. Russell AD. Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations. Lancet Infect Dis 2003; 3: 794-803.
13. Villalain J, Mateo CR, Aranda FJ et al. Membranotropic effects of the antibacterial agent triclosan. Arch Biochem Biophys 2001; 390: 128-36.
14. McMurry LM, Oethinger M, Levy SB. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett 1998; 166: 305-9.
15. Phan TN, Marquis RE. Triclosan inhibition of membrane enzymes and glycolysis of Streptococcus mutants in suspensions and biofilms. Can J Microbiol 2006; 52: 977-83.
16. Braun M, Silhavy TJ. Imp/OstA is required for cell envelope biogenesis in Escherichia coli. Mol Microbiol 2002; 45: 1289-302.
17. Sampson BA, Misra R, Benson SA. Identification and characterization of a new gene of Escherichia coli K-12 involved in outer membrane permeability. Genetics 1989; 122: 491-501.
18. Ruiz N, Falcone B, Kahne D et al. Chemical conditionality: a genetic strategy to probe organelle assembly. Cell 2005; 121: 307-17.
19. Singh MP, Petersen PJ, Weiss WJ et al. Mannopeptimycins, new cyclic glycopeptide antibiotics produced by Streptomyces hygroscopicus LL-AC98: antibacterial and mechanistic activities. Antimicrob Agents Chemother 2003; 47:62-9.
20. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 2000; 97: 6640-5.
21. Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 2008; 3: 163-75.
22. Tumah HN. Bacterial biocide resistance. J Chemother 2009; 21: 5-15.